Does Oric Pharmaceuticals (ORIC) Have the Potential to Rally 104.99% as Wall Street Analysts Expect?

Shares of Oric Pharmaceuticals, Inc. (ORIC) have gained 57.1% over the past four weeks to close the last trading session at $9.22, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $18.9 indicates a potential upside of 105%.The mean estimate comprises 10 short-term price targets with a standard deviation of $4.04. While the lowest estimate of $12.00 indicates a 30.2% increase from ...